Pharma Biz Lied About COVID-19 Drug's Prospects, Suit Says
NRx Pharmaceuticals was slapped with a proposed investor class action Tuesday claiming the company lied about the potential for Zyesami to get emergency use authorization to treat COVID-19, resulting in a...To view the full article, register now.
Already a subscriber? Click here to view full article